![]()
|
|
||||||||
(Received for publication, June 5, 1997, and in revised form, August 18, 1997)
From the Cancer Research Group, Institute for Molecular Biology and
Biotechnology, McMaster University, Hamilton,
Ontario, Canada L8N 3Z5
Epstein-Barr nuclear antigen 1 (EBNA1) activates
DNA replication from the Epstein-Barr virus latent origin of DNA
replication, oriP. EBNA1 binds cooperatively to four
recognition sites in the dyad symmetry (DS) element of
oriP, causing alterations in the origin DNA structure,
which can be detected by the increased sensitivity of one Thy residue
in two of the binding sites to permanganate oxidation. To better
understand the significance of this EBNA1-induced origin distortion, we
have investigated the DNA sequence and EBNA1 amino acid requirements
for permanganate sensitivity. We have shown that the EBNA1 DNA binding
and dimerization domains are sufficient to induce permanganate
sensitivity and that amino acids 463-467, which form an extended chain
that travels along the minor groove of the EBNA1 recognition site, play
an important role in generating the DNA distortion. The EBNA1-induced
permanganate sensitivity is independent of cooperative interactions
between EBNA1 molecules on the origin and requires a specific sequence within the EBNA1 binding site. Using synthetic EBNA1 binding sites, we
found that the inversion of a single AT base pair in the EBNA1 recognition sequence is sufficient to confer EBNA1-induced permanganate sensitivity. These studies indicate that permanganate oxidation can
detect very minor alterations in DNA structure.
The first step in the initiation of DNA synthesis in all
replication systems involves the melting of the origin DNA. In many systems the disruption of the hydrogen bonds between the bases is a
function of the origin binding protein, but in others the interaction
of the origin binding protein with the origin is not sufficient to melt
the DNA and additional factors are required (for review, see Refs.
1-3). Origin binding proteins that do not melt DNA might, however,
contribute to the melting process by destablizing the structure of the
DNA helix. To better understand how localized DNA distortions caused by
origin-binding proteins contribute to origin melting, we have examined
the structural changes in origin DNA induced by Epstein-Barr virus
nuclear antigen 1 (EBNA1).1
DNA replication from the Epstein-Barr virus latent origin of DNA
replication, oriP, occurs once every cellular S-phase and is
activated by EBNA1 (4-6). EBNA1 binds as a dimer to an 18-bp recognition site present in multiple copies in the two sub-elements of
oriP, the dyad symmetry (DS) element and the family of
repeats (FR) (7-10). The DS element contains four EBNA1 binding sites and likely the initiation site for DNA synthesis (7, 11-14). The FR
element contains 20 EBNA1 binding sites and enhances replication from
the DS element (7, 13).
The interaction of EBNA1 with the DS element has been studied by
several laboratories. In vivo studies have shown that EBNA1 remains bound to the DS throughout most or all of the cell cycle (12,
15) and that the minimum requirement for origin activation is the
binding of EBNA1 to the two recognition sites in either half of the DS
element (sites 1 and 2 or sites 3 and 4) (14). In vitro,
EBNA1 dimers have been shown to assemble cooperatively on the four
sites of the DS element (14, 16), generating a single EBNA1 complex
that sharply bends the DS DNA (17). EBNA1 on its own does not appear to
melt oriP DNA sequences; however, two lines of evidence
indicate that EBNA1 does cause localized structural distortion of the
DS element. First, EBNA1 binding to the DS element induces the
permanganate sensitivity of one Thy residue in each of the two outer
recognition sites (sites 1 and 4). This permanganate sensitivity has
been demonstrated both in vivo and in vitro (15,
18, 19). Second, modeling studies with the EBNA1-DNA co-crystal
structure suggest that a change in the DNA structure is necessary to
accomodate binding of EBNA1 to two adjacent sites in the DS element
(20).
The nature of the structural change in the DS DNA that leads to the
EBNA1-induced permanganate sensitivity is not known nor is it clear if
the DNA distortions predicted from the modeling and permanganate
studies are the same or different. Localized distortion of the DS DNA
by EBNA1 is of interest because it could be the first step in the
melting of the origin for the initiation of DNA synthesis. To further
understand the nature and importance of the EBNA1-induced distortion of
the DS DNA, we have examined the requirements for the EBNA1-induced
permanganate reactivity of sites 1 and 4.
The construction of pGEMdyad, which contains the DS
element of oriP, and pGEMs1, which contains only EBNA1
binding site 1 from the DS element, have been previously described (17,
21). Plasmids containing the palindromic EBNA1 consensus binding site (CS) or the consensus binding site with an inversion of the AT base
pairs at position 6 and bEBNA1 was produced in
SF-9 insect cells and purified to homogeneity as described previously
(9). EBNA459-619, EBNA463-607, and
EBNA468-607 were produced in E. coli and
purified to homogeneity as described previously (16, 22). For
expression of EBNAWF, the pET15b expression construct was
used to transform the BL21(DE3) pLysS strain of E. coli
(23), and transformants were grown at 37 °C in 2 liters of Super
Broth supplemented with 100 µg/ml ampicillin and 34 µg/ml
chloramphenicol until the A600 was 0.6-0.8.
Protein expression was induced with 1 mM
isopropyl- Permanganate assays were performed as
described previously (18). Briefly, EBNA1 proteins were incubated with
0.5 µg of supercoiled pGEMdyad, pGEMs1, pCS, or pCSA/T for 10 min at
37 °C in 20 µl of 50 mM HEPES, pH 7.5, 250 mM NaCl, 5 mM MgCl2.
KMnO4 was then added to a final concentration of 20 mM, and, after a 4-min incubation at 37 °C, the reaction
was quenched, the protein was removed, and the plasmid DNA was
heat-denatured. 32P-End-labeled oligonucleotide primers
were then hybridized to the denatured plasmids and extended with the
Klenow fragment of DNA polymerase I to detect the position of any
oxidized thymine residues, which act as a block to the polymerase. The
extension products were separated on 8% polyacrylamide/50% urea
sequencing gels and visualized by autoradiography. The positions of the
oxidized thymines were determined by comparison with dideoxy sequencing ladders generated from the same primers used for the permanganate assays.
EBNA1 proteins were
incubated with 0.5 µg of supercoiled pGEMdyad, pGEMs1, pCS, or pCSA/T
in 20 µl of 20 mM Tris-HCl, pH 7.5, 250 mM
NaCl, 5 mM MgCl2 for 10 min at 37 °C prior
to the addition of 10 mM dimethyl sulfate (DMS). After a
5-min incubation at 37 °C, the reactions were stopped, phenol was
extracted, and the DNA was cleaved with piperidine as described
previously (18). The DNA fragments generated were denatured and
hybridized to the same primers used in the permanganate assays, and the
primers were extended with the DNA polymerase I Klenow fragment as for
the permanganate assays. Extension products were separated on an 8% polyacrylamide/50% urea sequencing gel and visualized by
autoradiography.
Structural
changes in the DS element of oriP, which can be detected by
permanganate oxidation, are induced by wild type and internally deleted
versions of EBNA1 (15, 18, 19). We wished to determine if the DNA
binding and dimerization domains of EBNA1 were sufficient to induce
this DNA distortion or if other EBNA1 domains were required. To this
end, we compared the permanganate reactivity patterns of the DS element
when bound by EBNA459-619, which contains only the DNA
binding and dimerization domains, with that induced by a biologically
active version of EBNA1 (bEBNA1; Fig. 1).
As shown in Fig. 2, bEBNA1 and
EBNA459-619 generated identical permanganate reactivity
patterns when titrated onto the DS element. Both proteins caused one
Thy residue within EBNA1 binding site 1 and one Thy residue within
EBNA1 binding site 4, on the opposite DNA strand, to become oxidized by
KMnO4. For simplicity, results are shown for one DNA strand
only (detecting the oxidized T in site 1); however, in all cases where
permanganate sensitivity was detected in site 1, it was also detected
in site 4 (data not shown).
We have previously shown that amino acids 461 to 469 from the EBNA1
flanking DNA binding domain forms an extended amino acid chain that
travels along the minor groove of the EBNA1 recognition site (20) (see
Fig. 3). An EBNA1 truncation mutant
lacking this extended chain (EBNA468-607) retains the
ability to bind to high affinity EBNA1 recognition sites, such as sites
1 and 4, but is severely impaired in its ability to bind to lower
affinity sites, such as sites 2 and 3 of the DS element (16). To
determine if this interaction with the minor groove of the DNA causes
the distortion that results in permanganate sensitivity, we repeated the permanganate assays using EBNA468-607 and
EBNA463-607, which lack all or part of the extended chain,
respectively. The results in Fig. 2A show that
EBNA463-607, but not EBNA468-607, causes the
permanganate reactivity pattern seen with bEBNA1. The same results were
obtained for site 4 on the opposite DNA strand (data not shown). These
results suggest that the minor groove-extended chain of EBNA1 is
responsible for the permanganate sensitivity.
To verify that the failure of EBNA468-607 to induce
permanganate reactivity was not due to failure to bind the DS element, we performed methylation protection footprints with
EBNA468-607 on the DNA templates used for the
permanganate experiments. The results in Fig. 2B show
that all of the EBNA1 proteins, including EBNA468-607,
bound to the DS element at the protein concentrations used in the
permanganate experiments. For bEBNA1, EBNA459-619, and
EBNA463-607, simultaneous filling of the four
recognition sites of the DS was observed, at 10 to 30 pmol of protein
for both bEBNA1 and EBNA459-619 and at 90 pmol for
EBNA463-607. This is the same pattern of filling of the DS
that has been reported previously for bEBNA1 (18). In this assay,
binding to each of the four binding sites is indicated by the
lightening of the bands indicated by the arrows in Fig.
2B. Binding to site 4 is also detected by the appearance of
the band indicated by the asterisk, which represents a
DMS-hypersensitive adenine. Unlike the larger EBNA1 proteins,
EBNA468-607 was observed to bind only to sites 1 and 4 of
the DS (at 90-270 pmol of protein); interactions with sites 2 and 3 were not detected at any of the protein concentrations tested.
The failure
of EBNA468-607 to induce permanganate reactivity within
sites 1 and 4 of the DS element could be interpreted in either of two
ways. First, it might indicate that EBNA1 sequences between amino acid
463 and 468 are required to distort sites 1 and 4. Second, it might
indicate that binding to sites 2 and/or 3 is required for the induction
of permanganate reactivity within sites 1 and 4 since
EBNA468-607 was the only EBNA1 protein tested that did not
bind sites 2 and 3. To distinguish between these possibilities, we
repeated the permanganate assays on DNA templates that contained only
EBNA1 binding site 1 (pGEMs1). The results in Fig.
4 show that the binding of
EBNA459-619 and EBNA463-607 to site 1 alone
is sufficient to cause permanganate oxidation of the same Thy residue
that is reactive in the complete DS sequence. As was the case with the
DS DNA templates, induction of permanganate reactivity within site 1 with the pGEMs1 template was not induced by EBNA468-607.
These results indicate that EBNA1 sequences between amino acids 463 and
468 are required to distort site 1 and that binding to additional sites
in the DS is not required for this distortion. This DNA distortion is
independent of the supercoiling of the DNA template since the same
permanganate-sensitive T was induced in site 1 when experiments were
performed on linear, as opposed to supercoiled, DNA templates (Fig.
4A).
The methylation protection footprints shown in Fig. 4B
verify that all of the EBNA1 proteins tested, including
EBNA468-607, bound to site 1 at the concentrations used in
the permanganate reactions. The degree of protection of the diagnostic
band in site 1 (arrow) by EBNA468-607 was
somewhat less than that seen for the larger EBNA1 proteins; however,
the intensity of this band was still reduced compared with that seen in
the absence of protein (in the absence of protein the diagnostic band
is equal in intensity to the band just above it; with
EBNA468-607 it is less intense than the band above it).
These results suggest that EBNA468-607 may bind less
stably to site 1 than the other EBNA1 proteins.
The crystal structure of the EBNA1 DNA
binding and dimerization domains bound to DNA revealed a peculiar
arrangement of the Trp-464 and Phe-465 side chains within the minor
groove of the DNA (20) (see Fig. 3). The aromatic rings of these
residues are oriented parallel with the minor groove and appear to be
pushing on the two sugar phosphate backbones. The minor groove of the DNA is widened by 2-3 Å at this point (20). To determine whether Trp-464 and Phe-465 are responsible for generating the DNA disortion that leads to permanganate reactivity within site 1, we repeated the
permanganate assays using a version of EBNA1 that contains the complete
DNA binding and dimerization domains in which Trp-464 and Phe-465 have
been changed to alanine and serine residues, respectively
(EBNAWF; see Fig. 1). EBNAWF was shown by
electrophoretic mobility shift assays to bind site 1 with a 10-20-fold
reduced affinity relative to the same EBNA1 fragment containing the
wild-type sequence.2 When
EBNAWF was titrated onto pGEMs1, it was observed to induce permanganate oxidation of the same Thy residue as that seen with wild-type EBNA1 (Fig. 5). The amount of
protein required for this reactivity (30-90 pmol) corresponded to the
amount of protein required to bind site 1, as determined by methylation
protection footprints perfomed on the same DNA template (Fig. 5).
Therefore, the aromatic side chains of Trp-464 and Phe-465 are not
responsible for the DNA distortion that leads to permanganate
reactivity within site 1.
The results described above show that
EBNA1 binding to some individual recognition sites causes a change in
DNA structure leading to permanganate sensitivity. Ultimately, we would
like to determine the nature of the structural change in the DNA that results in permanganate reactivity. Previously we solved the structure of the EBNA1 DNA binding domain bound to a single EBNA1 binding site
(20). This binding site is a palindromic consensus sequence (Fig.
6) to which EBNA1 binds with high
affinity but which does not actually exist in oriP. In the
EBNA1-consensus DNA structure, there was no disruption of the hydrogen
bonds between the bases of the two DNA strands nor was there any other
obvious distortion of the DNA structure that might be expected to cause
permanganate sensitivity. However, since little is known about the DNA
structural requirements for permanganate oxidation, we tested the
EBNA1-induced permanganate sensitivity of the consensus EBNA1 binding
site. For these experiments, the consensus 18-bp binding site shown in
Fig. 6 was cloned into pBluescriptKS to generate pCS. When bEBNA1 and
EBNA459-619 were titrated onto pCS, binding to the
consensus site was detected by DMS footprint analysis at as little as
10 pmol of protein (Fig. 7B),
but no EBNA1-induced permanganate reactivity was detected at any amount
of protein tested (10-90 pmol) (Fig. 7A). Some degree of
permanganate reactivity was observed for Thy residues at positions 2 and
A comparison of the sequences of the EBNA1 binding sites in the origin
and the consensus EBNA1 binding site is shown in Fig. 6. For both of
the EBNA1 binding sites that have been shown to be permanganate
sensitive (sites 1 and 4 of the DS element), the permanganate-sensitive
T residue is located at position 6, relative to the axis of symmetry of
the 18-bp palindromic sites (see Fig. 6). Of the 24 EBNA1 bindings
sites in oriP (4 in the DS and 20 in the FR element), only
sites 1 and 4 of the DS have a Thy in this position. For the other
EBNA1 binding sites (and for the other half of the imperfect palindrome
in sites 1 and 4), there is an Ade at position 6 (and a Thy at position
Permanganate oxidation is commonly used to detect alterations in
the structure of DNA helices, but the structural requirements for
permanganate sensitivity are not well understood. While double-strand DNA is largely insensitive to permanganate oxidation, pyrimidines (particularly Ts) in single-strand DNA are oxidixed at the 5,6-double bond by this reagent to form pyrimidine glycols (24, 25). Therefore
permanganate is useful for the detection of melted regions of
double-strand DNA (26). In some cases, however, permanganate-sensitive residues have been detected in regions of double-strand DNA that, by
other criteria, are not melted. For example, the lac repressor (27),
SV40 large T antigen (28), repressor activator protein 1 (RAP1) (29),
and EBNA1 (18, 19) have all been reported to induce localized
structural changes in the DNA to which they bind, resulting in the
increased sensitivity of one or more T residues to permanganate
oxidation. The nature of the structural changes that cause these
permanganate sensitivities are not clear.
Although EBNA1 does not appear to melt oriP DNA, several
observations suggest that the interaction of this protein with its recognition sites in the DS element of oriP structurally
alters the DNA helix. First, electron microscopic studies of EBNA1 on the DS element show pronounced bending of the DS DNA at the position where the four EBNA1 dimers are assembled (17). Second, modeling studies using the EBNA1-DNA co-crystal structure suggest that the
cooperative assembly of EBNA1 dimers on adjacent binding sites in the
DS must be accompanied by a change in structure of the DNA, most likely
unwinding and/or unbending of the DNA (20). Third, EBNA1 binding to the
DS element, both in vivo and in vitro, has been
shown to induce permanganate sensitivity in one Thy residue in each of
the two outer EBNA1 binding sites (15, 18, 19).
The studies presented here were conducted to better understand the
nature of and the requirements for the EBNA1-induced distortion of the
DS element that results in permanganate sensitivity. We have shown that
this permanganate sensitivity occurs on single EBNA1 binding sites, and
therefore the DNA distortion detected by permanangate is distinct from
that predicted by the modeling studies to accompany cooperative
assembly of EBNA1 on two adjacent sites of the DS. This conclusion is
consistent with the results of Harrison et al. (14), who
showed that point mutations in sites 2 or 3 in the DS element did not
abrogate the EBNA1-induced permanganate sensitivity of sites 1 and 4 and that this sensitivity was independent of the spacing between the
EBNA1 binding sites. In their experiments, Harrison et al.
(14) used the full-length EBNA1 protein, which contains a domain that
mediates interactions at a distance between DNA-bound EBNA1 molecules
(21, 30-32). Therefore, although the cooperative filling of adjacent
sites was disrupted by virtue of their DNA templates, it is likely that interactions occurred between EBNA1 molecules on distant sites (i.e. between sites 1 and 4, 2 and 4, or 1 and 3, and
between different DNA molecules). Since EBNA1 interactions at a
distance might have substituted for the interaction between EBNA1
molecules on adjacent sites in inducing permanganate sensitivity, we
felt that it was important to test permanganate sensitivity under
conditions in which neither type of EBNA1 interaction was possible
(i.e. on individual binding sites using EBNA1 proteins that
lack the domain that mediates interactions at a distance).
We have explored the EBNA1 amino acids required to induce permanganate
reactivity and found that amino acids 463-607, containing the DNA
binding and dimerization domains of EBNA1, are sufficient to elicit
this response. Deletion of part of the flanking DNA binding domain that
forms an extended chain positioned along the base of the minor groove
of the EBNA1 binding site (amino acids 463-467) abrogated the ability
of EBNA1 to induce permanganate reactivity. We have previously shown,
using electrophoretic mobility shift assays, that this deletion had
little effect on the ability of EBNA1 to bind to site 1 from the DS
element (Kd for EBNA463-607 and
EBNA468-607 was 110 and 125 nM, respectively) (16). The methylation protection footprints presented here also confirm
that EBNA468-607 binds site 1, both in the context of the
DS element and in isolation. However, the weaker footprint generated by
this protein suggests that EBNA468-607 binds less tightly
to site 1 than the larger versions of EBNA1 tested. Therefore, the
requirement for amino acids 463-467 for permanganate reactivity could
either reflect a specific requirement for the extended chain in the
minor groove of the DNA or a requirement for tight binding. We favor
the former possibility because other mutations in the EBNA1-flanking
DNA binding domain that reduce binding to site 1 still induce
permanganate sensitivity. An example of this is the EBNAWF
mutant. This mutant gives a weaker footprint on site 1 (Fig. 5) and
binds site 1 with an affinity that is approximately 15-fold lower than
the same fragment of EBNA1 with the wild-type sequence (as
determined by electrophoretic mobility shift assays),2 yet
EBNAWF still induces permanganate reactivity in site 1.
Investigation of the DNA sequence requirements for EBNA1-induced
permanganate reactivity revealed that the differences in permanganate
sensitivity of different EBNA1 binding sites is soley due to the
inversion of a single AT base pair at position 6/ We have already solved the structure of the EBNA1 DNA binding and
dimerization domains on the consensus binding site that is not
permanganate sensitive (20). In keeping with the results of the
permanganate assays on the consensus site, distortion of the DNA helix
at position 6/ We gratefully acknowledge Dr. Alexey
Bochkarev for Fig. 3, Elena Bochkareva for the pCS and pCSA/T
constructs, and Kathy Shire for technical assistance. We also thank Dr.
Aled Edwards for helpful comments throughout the course of this work
and critical reading of the manuscript.
Volume 272, Number 42,
Issue of October 17, 1997
pp. 26434-26440
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Requirements for Epstein-Barr Nuclear Antigen 1 (EBNA1)-induced
Permanganate Sensitivity of the Epstein-Barr Virus Latent Origin of DNA
Replication*

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
DNA
6 (CSA/T) were constructed from the
oligonucleotides 5
-GGGTAGCATATGCTACCC-3
and 5
-GGGAAGCATATGCTTCCC-3
, respectively. Each of these oligonucleotides was annealed to itself and
then cloned into the SmaI site of pBluescriptKS to generate pCS and pCSA/T. The construct for the expression of EBNAWF
was generated by amplifying the EBNA1 gene in two fragments, which encode amino acids 452 to 463 and amino acids 464 to 641, by PCR. The
452-463 fragment was amplified using the primers
5
-CGTCGACATATGGGTCAGGGTGAT-3
(452 primer) and
5
-CCCTCCTTTTTTGCGCCT-3
. The 464-641 fragment was amplified using the
primers 5
-GCGGCGGGAAAGCATCGTGGTCAA-3
and
5
-CCTCCAGGATCCTCACTCCTGCCCTTCCTCACC-3
(641 primer), which converts
the Trp and Phe residues at positions 464 and 465 to alanines. The two
fragments of the EBNA1 gene were phosphorylated using T4 polynucleotide
kinase and ligated together. The ligation products were amplified by
PCR using the 452 and 641 primers listed above, which generates an
NdeI site at the N terminus and a BamHI site at
the C terminus. PCR products were digested with NdeI and BamHI and inserted between the NdeI and
BamHI sites of expression vector pET15b (Novagen),
downstream of a 6-histidine tag. The EBNA1 fragment in this construct
was sequenced and confirmed to be correct except that amino acid 465 was converted to a serine instead of an alanine.
-D-thiogalactopyranoside, and cells were
harvested 3 h postinduction. Cell pellets were rinsed in
phosphate-buffered saline and then stored at
70 °C. For protein
purification, cells were thawed in 10 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 10% sucrose, 350 mM NaCl,
1 mM EDTA, 1 mM benzamidine and 1 mM PMSF) and sonicated to reduce the viscosity. Lysates
were clarified by centrifugation at 100,000 × g for 30 min, and the supernatant was applied to a DE52 column containing 4 g of resin equilibrated in lysis buffer. The DE52 flow-through was
diluted with 50 mM HEPES, pH 7.5, to a final NaCl
concentration of 200 mM and then loaded onto a 20-ml
heparin-agarose column equilibrated with buffer A (50 mM
HEPES, pH 7.5, 200 mM NaCl, 10% glycerol, 1 mM
EDTA, 1 mM dithiothreitol, 1 mM PMSF, 1 mM benzamidine). The column was washed with buffer A and
then developed with buffer A containing 750 mM NaCl. The
eluted protein was dialyzed against buffer B (50 mM HEPES,
pH 7.5, 750 mM NaCl, 10% glycerol, 1 mM PMSF,
1 mM benzamidine) and loaded onto a 1-ml metal chelating
column charged with nickel and equilibrated in buffer B plus 5 mM imidazole. The column was washed with buffer B plus 5 mM imidazole and then with buffer B plus 50 mM
imidazole. The 6-histidine-tagged EBNAWF was eluted with
buffer B plus 300 mM imidazole and was dialyzed against 50 mM HEPES, pH 7.5, 500 mM NaCl, 10% glycerol.
CaCl2 was added to 2.5 mM, and the 6-histidine tag was removed from EBNAWF by thrombin digestion (10 units/mg protein) overnight at 4 °C followed by dialysis against 50 mM HEPES, pH 7.5, 500 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM dithiothreitol.
EBNA1 Amino Acids Required for DS DNA Distortion
Fig. 1.
The EBNA1 mutants. EBNA1 amino acid
numbers are indicated, as are the core and flanking DNA binding domains
(20) and the nonessential Gly-Ala repeat (6).
[View Larger Version of this Image (32K GIF file)]
Fig. 2.
EBNA1 amino acid requirements for DS
permanganate sensitivity. A, bEBNA1,
EBNA459-619, EBNA463-607, and EBNA468-607 were titrated onto supercoiled plasmids
containing the DS element, and permanganate assays were performed as
described under "Experimental Procedures." The positions of the
four EBNA1 binding sites in the DS element are indicated as is the
position of the permanganate-sensitive Thy residue in site 1 (arrow). B, methylation protection footprints
performed with the same proteins and DNA template as in panel
A. Arrows indicate the position of the Gua residue in
each of the four binding sites that is most obviously and most
reproducibly protected by EBNA1. A DMS-hyper-reactive Ade that is
induced when EBNA1 binds to site 4 is also indicated (*).
[View Larger Version of this Image (63K GIF file)]
Fig. 3.
Ribbon diagram of the co-crystal structure of
EBNA459-607 bound to the consensus binding site as
determined by Bochkarev et al. (20). For one EBNA1 monomer,
side chains are shown for the amino acids that form the extended chain
in the minor groove of the DNA. The positions of amino acids 463, 464 (W), 465 (F), and 468 are indicated. The AT base
pair at position 6/
6 in both halves of the palindrome is shown in
bold.
[View Larger Version of this Image (84K GIF file)]
Fig. 4.
Interactions of EBNA1 mutants with isolated
site 1. EBNA1 proteins were titrated onto pGEMs1 containing site
1. A, permanganate assays performed on supercoiled
(left panel) and linear (right panel) DNA
templates. The position of the EBNA1-induced permanganate-sensitive Thy
in site 1 is indicated (arrow). B, methylation
protection footprints performed on supercoiled pGEMs1. Arrow
indicates the position of the Gua residue that is most obviously and
most reproducibly protected by EBNA1.
[View Larger Version of this Image (74K GIF file)]
Fig. 5.
The role of W464 and F465 in site 1 distortion. EBNAWF was titrated onto pGEMs1, and
permanganate assays (KMnO4) or methylation
footprints (DMS) were performed. Arrows mark the
position of the permanganate-sensitive T in the permanganate assay and the protected G in the methylation protection footprints.
[View Larger Version of this Image (42K GIF file)]
1 within the consensus sequence, but this sensitivity was
independent of EBNA1.
Fig. 6.
EBNA1 binding sites. The four EBNA1
binding sites from the DS element and the consensus binding site with
and without the AT inversion at position 6/
6 are shown. EBNA1-induced
permanganate-sensitive Thy residues are in bold type.
[View Larger Version of this Image (28K GIF file)]
Fig. 7.
The effect of the inversion of the AT base
pair at position 6/
6 on permanganate sensitivity. bEBNA1 and
EBNA459-619 were titrated onto pCS or pCSA/T plasmids
(numbers shown are pmol of dimer), and permanganate assays
(A) or methylation protection footprints (B) were
performed. The position of the EBNA1 binding site is indicated by the
open box. In panel A, the 6 and
6 positions of
the EBNA1 recognition sites are indicated, and sequencing reactions (G,
A, T, C) are shown for each DNA template. In panel B, bands from the two DNA templates that become protected by EBNA1 are indicated
by the arrow.
[View Larger Version of this Image (113K GIF file)]
6) i.e. an inversion of the AT base pair relative to the
permanganate-sensitive Thy in sites 1 and 4. The lack of permanganate
reactivity of the Thy residues at position
6 suggests that inversion
of the AT base pair at position 6/
6 affects the structure of the
EBNA1-bound DNA. To determine if the inversion of this AT base pair is
sufficient to elicit the EBNA1-induced structural change, we
constructed a perfect palindromic EBNA1 binding site that is identical
to the consensus site except that the AT base pair at position 6/
6 in
both halves of the palindrome has been inverted (Fig. 6, AT inversion).
When bEBNA1 and EBNA459-619 were titrated with a plasmid
containing this sequence, both proteins were observed to induce
permanganate oxidation of the Thy at position 6 (Fig. 7). Therefore,
the inversion of the AT base pair at position 6/
6 of the EBNA1
binding site enables the structural change that accompanies EBNA1
binding.
6 relative to the
axis of dyad symmetry of the palindromic binding site. Permanganate
sensitivity is only seen when the Thy residue is at position 6, generating the sequence CCCTTCGTA. This suggests that EBNA1 binding to
this sequence causes a distortion in the DNA structure that does not
occur when EBNA1 binds to recognition sites containing the sequence
CCCATCGTA. This distortion might be facilitated by the 6-bp
polypurine/polypyrimidine tract that is generated by the AT inversion
since polypurine/polypyrimidine tracts have a tendency to adopt
alternative DNA structures (33). Alternatively, the structures of the
EBNA1-bound CCCTTCGTA and CCCATCGTA binding sites might be the same,
and the Thy residue at position
6 might simply be inaccessible to the
permanganate reagent due to postioning of EBNA1 amino acids. These two
alternative interpretations can only be resolved by solving the high
resolution structure of the EBNA1 DNA binding and dimerization domains
on binding sites that are and are not permanganate-sensitive.
6 was not apparent from this structure. We have also
solved the structure of the EBNA1 DNA binding domain on the
permanganate-sensitive site 1 at 2.8 Å resolution.3 The structure of
the site 1 DNA was indistinguishable from that of the consensus site,
however the particular packing arrangement of EBNA1 in the crystal form
used to solve the structure would permit the EBNA1-DNA complex to
crystallize in either of two orientations. As a result, the final
structure of the site 1 DNA might represent an average of the two
halves, and hence even moderate structural perturbations on one side of
the pseudopalindromic DNA may not be revealed. To conclusively
determine the structure of EBNA1-bound permanganate-sensitive DNA, we
require a palindromic permanganate-sensitive EBNA1 binding site in
which the structural distortion would be manifested on both halves of
the palindrome. We have shown that we can generate such a binding site
by inverting the AT base pair at position 6/
6 in both halves of the
consensus palindrome. This finding should facilitate the structural
determination of permanangate-sensitive DNA bound by EBNA1, which in
turn will help us to understand the structural requirements for
permanganate oxidation.
*
This work was supported by a grant from the National Cancer
Insititute of Canada (NCIC), which recieves funds from the Canadian Cancer Society.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Research Scientist of the NCIC. Present address and to whom
correspondence should be addressed: Dept. of Medical Genetics and
Microbiology, University of Toronto, 1 Kings College Circle, Toronto,
Ontario, Canada M5S 1A8. Tel.: 416-946-3501; Fax: 416-978-6885.
1
The abbreviations used are: EBNA1, Epstein-Barr
nuclear antigen 1; bp, base pair(s); DS, dyad symmetry; FR, family of
repeats; CS, consensus binding site; CSA/T, consensus binding site with an inversion of the AT base pairs; PCR, polymerase chain reaction; PMSF, phenylmethylsulfonyl fluoride; DMS, dimethyl sulfate.
2
A. Fleming, and L. Frappier, unpublished
data.
3
A. Bochkarev, A. Edwards, and L. Frappier,
unpublished data.
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. F. J. Ceccarelli and L. Frappier Functional Analyses of the EBNA1 Origin DNA Binding Protein of Epstein-Barr Virus J. Virol., June 1, 2000; 74(11): 4939 - 4948. [Abstract] [Full Text] |
||||
![]() |
J. L. Yates, S. M. Camiolo, and J. M. Bashaw The Minimal Replicator of Epstein-Barr Virus oriP J. Virol., May 15, 2000; 74(10): 4512 - 4522. [Abstract] [Full Text] |
||||
![]() |
J. Cruickshank, K. Shire, A. R. Davidson, A. M. Edwards, and L. Frappier Two Domains of the Epstein-Barr Virus Origin DNA-binding Protein, EBNA1, Orchestrate Sequence-specific DNA Binding J. Biol. Chem., July 14, 2000; 275(29): 22273 - 22277. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |